Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Agios Pharmaceuticals Inc shares valued at $142,338 were sold by Burns James William on Mar 03 ’25. At $35.54 per share, Burns James William sold 4,005 shares. The insider’s holdings dropped to 18,650 shares worth approximately $0.59 million following the completion of this transaction.
Also, Jones Cecilia sold 2,275 shares, netting a total of over 80,854 in proceeds. Following the sale of shares at $35.54 each, the insider now holds 21,843 shares.
Before that, Milanova Tsveta had sold 1,681 shares from its account. In a trade valued at $59,743, the Chief Commercial Officer traded Agios Pharmaceuticals Inc shares for $35.54 each. Upon closing the transaction, the insider’s holdings decreased to 1,681 shares, worth approximately $0.73 million.
As published in their initiating research note from H.C. Wainwright on February 24, 2025, Agios Pharmaceuticals Inc [AGIO] has been a Buy and the price target has been revised to $58. Analysts at Scotiabank started covering the stock with ‘”a Sector outperform”‘ outlook in a report released in mid October. Earlier on September 27, 2024, Leerink Partners downgraded its rating. Their new recommendation was “a Market perform” for AGIO stock which previously was a “an Outperform”.
Analyzing AGIO Stock Performance
During the last five days, there has been a drop of approximately -0.94%. Over the course of the year, Agios Pharmaceuticals Inc shares have dropped approximately -3.59%. Shares of the company reached a 52-week high of $36.17 on 02/24/25 and a 52-week low of $30.64 on 03/17/25. A 50-day SMA is recorded $33.57, while a 200-day SMA reached $42.77.
Support And Resistance Levels for Agios Pharmaceuticals Inc (AGIO)
According to the 24-hour chart, there is a support level at 31.21, which, if violated, would cause prices to drop to 30.73. In the upper region, resistance lies at 31.95. The next price resistance is at 32.21. RSI (Relative Strength Index) is 41.76 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.90, which suggests the price will decrease in the coming days. Percent R is at 79.45%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
